Elevated serum calprotectin (S100A8/A9) in patients with severe asthma
ConclusionIn conclusion, there was no difference in SC levels between the different inflammatory subtypes in asthmatics. Nevertheless, severe asthmatics seemed to have higher SC levels suggesting that SC may be a marker of disease severity rather than a marker for specific inflammatory subtypes in asthmatics. Further research in larger cohorts is necessary to validate SC as biomarker in severe asthmatics.PMID:33830849 | DOI:10.1080/02770903.2021.1914649
Source: Journal of Asthma - Category: Respiratory Medicine Authors: T Decaesteker S Bos N Lorent S Everaerts J Vanoirbeek D Bullens L J Dupont Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Corticosteroid Therapy | Cystic Fibrosis | Respiratory Medicine | Study